METIS TECHBIO-P's stock plummeted 5.48% during intraday trading on Tuesday, continuing its downward trend after a spectacular debut on the Hong Kong Stock Exchange.

The decline reflects waning initial enthusiasm for the newly listed stock, which surged over 173% on its debut but has since faced continuous pullback. Market participants note that certain international placement shares carry no lock-up period, creating significant profit-taking pressure as early investors cash out their gains.

Adding to the selling momentum, the company remains in its early commercialization stage with volatile revenue and has accumulated approximately RMB 1.5 billion in losses over the past three years. As the new stock premium dissipates, selling pressure has intensified, pushing the share price further below its first-day highs.